Effects of fingolimod treatments on alanine transaminase and aspartate transaminase levels in patients with multiple sclerosis

Introduction: Multiple Sclerosis (MS) is a chronic neurological disorder with no known cause or cure. Fingolimod (FTY720) is an oral medication recently approved for the treatment of MS as well as other diseases with autoimmune aspects. However, the drug is not without side effects. The severity and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Physiol Pathophysiol Pharmacol
Asıl Yazarlar: Joni, Saeid Sadeghi, Cheshmavar, Masoumeh, Shoureshi, Pouria, Zamani, Zohreh, Taoosi, Niusha, Akbari, Morteza, Afzali, Mahdieh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: e-Century Publishing Corporation 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364390/
https://ncbi.nlm.nih.gov/pubmed/32714497
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller